Cargando…
Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
This was a randomized, placebo-controlled, Phase I/II study conducted in a Japanese cohort to assess the safety and immunogenicity of Clostridium difficile vaccine (the same formulation as that used in the ongoing global Phase III study). Healthy Japanese adults aged 40–75 years were randomized to r...
Autores principales: | Matsuoka, Osamu, Patel, Dhaval M., Sasaki, Shin, Oka, Hayato, Sasaki, Toru, Pietrobon, Patricia J., Laot, Thelma, Bouckenooghe, Alain, Menezes, Josemund, de Bruyn, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806652/ https://www.ncbi.nlm.nih.gov/pubmed/29116880 http://dx.doi.org/10.1080/21645515.2017.1395538 |
Ejemplares similares
-
Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting
por: Quemeneur, Laurence, et al.
Publicado: (2018) -
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
por: Donald, Robert G. K., et al.
Publicado: (2013) -
Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
por: Dubey, Anand Prakash, et al.
Publicado: (2015) -
Development of a subunit vaccine for prevention of Clostridium difficile associated diseases: Biophysical characterization of toxoids A and B
por: Gribenko, Alexey, et al.
Publicado: (2017) -
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)